Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Blood Cancer Journal (9)
Leukemia (1)
Bone Marrow Transplantation (1)
Nature Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (7)
Correspondence (4)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Health care
Immunology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–12 of 12 results

Advanced filters: Author: Carlyn R. Tan Clear advanced filters

Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

Tara Sebastian
Sridevi Rajeeve
Hamza Hashmi
Amendments and CorrectionsOpen Access13 Oct 2025
Blood Cancer Journal

Volume: 15, P: 1
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma

Hamza Hashmi
Tara Sebastian
Saad Z. Usmani
ResearchOpen Access12 Apr 2026
Blood Cancer Journal

Volume: 16, P: 1-8
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

Ross S. Firestone
Anish K. Simhal
Malin Hultcrantz
CorrespondenceOpen Access01 May 2026
Blood Cancer Journal

Volume: 16, P: 1-4
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens

Using whole-genome and single-cell RNA sequencing data of patients with multiple myeloma treated with carfilzomib, lenalidomide, dexamethasone and daratumumab, Maura et al. identify distinct genomic drivers and microenvironment changes affecting outcome.

Francesco Maura
Eileen M. Boyle
Ola Landgren
Research09 Nov 2023
Nature Cancer

Volume: 4, P: 1660-1674
Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis

Hira Mian
Thomas G. Martin
Carlyn Rose Tan
Research20 Mar 2025
Leukemia

Volume: 39, P: 1252-1255
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma

Bruno Almeida Costa
Jessica Flynn
Sham Mailankody
ResearchOpen Access27 May 2024
Blood Cancer Journal

Volume: 14, P: 1-8
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma

Eric Jurgens
Tala Shekarkhand
Zainab Shahid
CorrespondenceOpen Access01 Nov 2025
Blood Cancer Journal

Volume: 15, P: 1-5
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study

Carlyn Rose Tan
Sireesha Asoori
Yi Lin
ResearchOpen Access03 Apr 2025
Blood Cancer Journal

Volume: 15, P: 1-10
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma

Carlyn Rose Tan
Andriy Derkach
Neha Korde
ResearchOpen Access25 Jul 2023
Blood Cancer Journal

Volume: 13, P: 1-8
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

Karthik Nath
Tala Shekarkhand
Alexander M. Lesokhin
ResearchOpen Access31 May 2024
Blood Cancer Journal

Volume: 14, P: 1-8
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients

Carlyn Rose Tan
Noel Estrada-Merly
Anita D’Souza
Correspondence20 Nov 2021
Bone Marrow Transplantation

Volume: 57, P: 295-298
Nutrition perceptions, needs and practices among patients with plasma cell disorders

Maria A. Malik
Nathan W. Sweeney
Urvi A. Shah
CorrespondenceOpen Access20 Apr 2022
Blood Cancer Journal

Volume: 12, P: 1-5